ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 283 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,565,095 | +529.6% | 71,932 | +348.5% | 0.07% | +509.1% |
| Q1 2023 | $407,391 | -89.8% | 16,039 | -83.7% | 0.01% | -90.3% |
| Q4 2022 | $3,993,456 | +343.7% | 98,458 | +285.3% | 0.11% | +182.5% |
| Q2 2022 | $900,000 | +1.2% | 25,555 | +32.2% | 0.04% | -4.8% |
| Q1 2022 | $889,000 | +89.6% | 19,330 | +173.2% | 0.04% | +44.8% |
| Q4 2021 | $469,000 | -26.1% | 7,075 | -7.7% | 0.03% | -46.3% |
| Q2 2021 | $635,000 | -52.7% | 7,665 | -62.1% | 0.05% | -56.1% |
| Q1 2021 | $1,342,000 | -21.1% | 20,244 | -24.5% | 0.12% | +21.8% |
| Q4 2019 | $1,701,000 | +1123.7% | 26,812 | +39.2% | 0.10% | +910.0% |
| Q1 2018 | $139,000 | – | 19,260 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |